Petra Doze

421 total citations
18 papers, 346 citations indexed

About

Petra Doze is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Petra Doze has authored 18 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Petra Doze's work include Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Medical Imaging Techniques and Applications (3 papers). Petra Doze is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Medical Imaging Techniques and Applications (3 papers). Petra Doze collaborates with scholars based in Netherlands, France and Switzerland. Petra Doze's co-authors include Aren van Waarde, Willem Vaalburg, Philip H. Elsinga, W Vaalburg, P. H. Elsinga, Jan Passchier, Erik F. J. de Vries, N. Harry Hendrikse, Antoon T. M. Willemsen and Antonella Calogero and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and European Journal of Pharmacology.

In The Last Decade

Petra Doze

18 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra Doze Netherlands 12 150 89 80 71 54 18 346
Igor Khait United States 13 291 1.9× 65 0.7× 67 0.8× 11 0.2× 31 0.6× 27 545
W.C. Eckelman United States 12 174 1.2× 193 2.2× 73 0.9× 57 0.8× 11 0.2× 24 429
Johannes Penzien Germany 10 309 2.1× 48 0.5× 31 0.4× 21 0.3× 105 1.9× 12 499
P. Gashkoff United States 5 183 1.2× 197 2.2× 38 0.5× 21 0.3× 47 0.9× 6 439
R.E. Gibson United States 14 212 1.4× 126 1.4× 96 1.2× 33 0.5× 6 0.1× 28 395
Benoit Jégo France 12 122 0.8× 107 1.2× 62 0.8× 47 0.7× 14 0.3× 23 411
Tamara J. van Steeg Netherlands 10 98 0.7× 67 0.8× 25 0.3× 62 0.9× 31 0.6× 20 294
Charlie W. Zhao United States 8 418 2.8× 22 0.2× 64 0.8× 29 0.4× 13 0.2× 24 647
Emi Hayashinaka Japan 13 123 0.8× 51 0.6× 27 0.3× 112 1.6× 74 1.4× 24 392
Axel W. Fischer United States 11 182 1.2× 13 0.1× 98 1.2× 77 1.1× 19 0.4× 16 519

Countries citing papers authored by Petra Doze

Since Specialization
Citations

This map shows the geographic impact of Petra Doze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Doze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Doze more than expected).

Fields of papers citing papers by Petra Doze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Doze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Doze. The network helps show where Petra Doze may publish in the future.

Co-authorship network of co-authors of Petra Doze

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Doze. A scholar is included among the top collaborators of Petra Doze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Doze. Petra Doze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Brandão, Mariana, Jon Zugazagoitia, Anne‐Marie C. Dingemans, et al.. (2024). Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in non-small-cell lung cancer (NSCLC) with c-METexon 14 skipping mutations (METex14).. Journal of Clinical Oncology. 42(16_suppl). 8583–8583. 3 indexed citations
2.
Waarde, Aren van, Bram Maas, Petra Doze, et al.. (2005). Positron Emission Tomography Studies of Human Airways Using an Inhaled β-Adrenoceptor Antagonist, S-11 C-CGP 12388. CHEST Journal. 128(4). 3020–3027. 15 indexed citations
3.
Waarde, Aren van, Willem Vaalburg, Petra Doze, Fokko J. Bosker, & Philip H. Elsinga. (2004). PET Imaging of Beta-Adrenoceptors in Human Brain: A Realistic Goal or a Mirage?. Current Pharmaceutical Design. 10(13). 1519–1536. 23 indexed citations
4.
Doze, Petra, Philip H. Elsinga, Aren van Waarde, et al.. (2002). Quantification of β-adrenoceptor density in the human heart with (S)-[11C]CGP 12388 and a tracer kinetic model. European Journal of Nuclear Medicine and Molecular Imaging. 29(3). 295–304. 22 indexed citations
5.
Doze, Petra, Aren van Waarde, Timothy J. Tewson, Willem Vaalburg, & Philip H. Elsinga. (2002). Synthesis and evaluation of (S)-[18F]-fluoroethylcarazolol for in vivo β-adrenoceptor imaging in the brain. Neurochemistry International. 41(1). 17–27. 8 indexed citations
6.
Doze, Petra, et al.. (2002). Synthesis and evaluation of radiolabeled antagonists for imaging of β-adrenoceptors in the brain with PET. Neurochemistry International. 40(2). 145–155. 22 indexed citations
7.
Waarde, Aren van, et al.. (2002). PET studies of human airways using inhaled C-11 CGP 12388.. Data Archiving and Networked Services (DANS). 43(5). 1 indexed citations
8.
Elsinga, Philip H., Petra Doze, Aren van Waarde, et al.. (2001). Imaging of β-adrenoceptors in the human thorax using (S)-[11C]CGP12388 and positron emission tomography. European Journal of Pharmacology. 433(2-3). 173–176. 16 indexed citations
9.
Elsinga, Philip H., et al.. (2001). Synthesis and evaluation of radiolabelled antagonists for beta‐adrenoceptor imaging in the brain with pet. Journal of Labelled Compounds and Radiopharmaceuticals. 44(S1). 2 indexed citations
10.
Doze, Petra, et al.. (2000). Enhanced cerebral uptake of receptor ligands by modulation of P-glycoprotein function in the blood-brain barrier. Synapse. 36(1). 66–74. 44 indexed citations
11.
Visser, Ton J., et al.. (2000). Synthesis and biodistribution of [11C]procaterol, a β2-adrenoceptor agonist for positron emission tomography. Applied Radiation and Isotopes. 52(4). 857–863. 7 indexed citations
12.
Doze, Petra, P. H. Elsinga, Erik F. J. de Vries, Aren van Waarde, & Willem Vaalburg. (2000). Mutagenic activity of a fluorinated analog of the beta-adrenoceptor ligand carazolol in the Ames test. Nuclear Medicine and Biology. 27(3). 315–319. 14 indexed citations
13.
14.
Passchier, Jan, Aren van Waarde, Petra Doze, P. H. Elsinga, & W Vaalburg. (2000). Influence of P-glycoprotein on brain uptake of [18F]MPPF in rats. European Journal of Pharmacology. 407(3). 273–280. 51 indexed citations
15.
Hospers, Geke A.P., Antonella Calogero, Aren van Waarde, et al.. (2000). Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomography.. PubMed. 60(6). 1488–91. 53 indexed citations
16.
Doze, Petra, et al.. (1998). Validation of S-1′-[]fluorocarazolol for in vivo imaging and quantification of cerebral β-adrenoceptors. European Journal of Pharmacology. 353(2-3). 215–226. 19 indexed citations
17.
Waarde, Aren van, et al.. (1998). A novel β-adrenoceptor ligand for positron emission tomography: Evaluation in experimental animals. European Journal of Pharmacology. 343(2-3). 289–296. 22 indexed citations
18.
Visser, Ton J., Aren van Waarde, Petra Doze, et al.. (1998). Characterisation of β2-adrenoceptors, using the agonist []formoterol and positron emission tomography. European Journal of Pharmacology. 361(1). 35–41. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Igor Khait Breakdown of academic impact, for papers by W.C. Eckelman Breakdown of academic impact, for papers by Johannes Penzien Breakdown of academic impact, for papers by P. Gashkoff Breakdown of academic impact, for papers by R.E. Gibson Breakdown of academic impact, for papers by Benoit Jégo Breakdown of academic impact, for papers by Tamara J. van Steeg Breakdown of academic impact, for papers by Charlie W. Zhao Breakdown of academic impact, for papers by Emi Hayashinaka Breakdown of academic impact, for papers by Axel W. Fischer
Rankless by CCL
2026